| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXC | Common Stock | +Options Exercise | +1,365 | +8% | 18,433 | Jan 29, 2024 | Direct | F1 | ||
| transaction | EXC | Common Stock | +Options Exercise | +1,186 | +6.43% | 19,619 | Jan 29, 2024 | Direct | F1 | ||
| transaction | EXC | Common Stock | +Options Exercise | +1,373 | +7% | 20,992 | Jan 29, 2024 | Direct | F1 | ||
| transaction | EXC | Common Stock | +Options Exercise | +9,569 | +45.58% | 30,561 | Jan 29, 2024 | Direct | F2 | ||
| transaction | EXC | Common Stock | -Tax liability | -$145,959 | -4,136 | -13.53% | $35.29 | 26,425 | Jan 29, 2024 | Direct | |
| transaction | EXC | Common Stock | -Disposed to Issuer | -$119,492 | -3,386 | -12.81% | $35.29 | 23,039 | Jan 29, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXC | 2024 Restricted Stock Units | +Grant/Award | +4,676 | 4,676 | Jan 29, 2024 | Common Stock | 4,676 | Direct | F1 | ||||
| transaction | EXC | 2023 Restricted Stock Units | -Options Exercise | -1,365 | -33.33% | 2,730 | Jan 29, 2024 | Common Stock | 1,365 | Direct | F1, F3 | |||
| transaction | EXC | 2022 Restricted Stock Units | -Options Exercise | -1,186 | -50.06% | 1,183 | Jan 29, 2024 | Common Stock | 1,186 | Direct | F1, F4 | |||
| transaction | EXC | 2021 Restricted Stock Units | -Options Exercise | -1,373 | -100% | 0 | Jan 29, 2024 | Common Stock | 1,373 | Direct | F1, F5 | |||
| transaction | EXC | 2021-2023 Performance Shares | +Grant/Award | +9,569 | 9,569 | Jan 29, 2024 | Common Stock | 9,569 | Direct | F2 | ||||
| transaction | EXC | 2021-2023 Performance Shares | -Options Exercise | -9,569 | -100% | 0 | Jan 29, 2024 | Common Stock | 9,569 | Direct | F2 | |||
| holding | EXC | Retention RSUs | 21,371 | Jan 29, 2024 | Common Stock | 21,371 | Direct | F6, F7 | ||||||
| holding | EXC | Deferred phantom share equivalents | 1,674 | Jan 29, 2024 | Common Stock | 1,674 | Direct | F8, F9 |
| Id | Content |
|---|---|
| F1 | Restricted stock unit (RSU) award granted under the Exelon LTIP. Award vests in 1/3 increments at the January or February meeting of the Exelon Comp. Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award. |
| F2 | Performance share award granted under the Exelon LTIP for the three-year performance period referenced in Column 1 based upon the Comp. Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date. |
| F3 | Pre-vesting balance includes 622 shares acquired through automatic dividend reinvestment during 2023. |
| F4 | Pre-vesting balance includes 83 shares acquired through automatic dividend reinvestment during 2023. |
| F5 | Pre-vesting balance includes 48 shares acquired through automatic dividend reinvestment during 2023. |
| F6 | Balance includes 752 shares acquired through automatic dividend reinvestment during 2023. |
| F7 | Restricted stock unit (RSU) award granted under the Exelon LTIP on February 25, 2022. Each RSU represents the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award. The award will cliff vest on February 25, 2025. |
| F8 | Balance includes additional 15 phantom share equivalents that were accrued through automatic dividend reinvestment during 2023 which were not reported on previously filed forms. |
| F9 | Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units. |